Last reviewed · How we verify
NCT02553967: REMASCO
Breast Reconstruction and Body Map : Assessment by Functional MRI (REMASCO)
NA trial testing Functional MRI in Breast Cancer in 49 participants. Completed in 15 April 2021.
25 November 2019
Quick facts
| Lead sponsor | Centre Oscar Lambret |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | basic science |
| Enrollment | 49 |
| Start date | 7 January 2016 |
| Primary completion | 25 November 2019 |
| Estimated completion | 15 April 2021 |
| Sites | 1 location across France |
Drugs / interventions tested
- Functional MRI
Conditions studied
- Breast Cancer — all drugs for Breast Cancer →
Sponsor
Centre Oscar Lambret — full company profile →
Who can join
18 and older, female only, with Breast Cancer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Breast reconstruction is an integral part of the management of patients with breast cancer and treated by total mastectomy. The aim of breast reconstruction is to get a satisfying aesthetic and functional result (sensitivity) and that would enable the patient to appropriate the reconstructed breast. Patient satisfaction assessed subjectively by questionnaires would be better in autologous reconstructions than in reconstructions by prosthesis. The aim of our trial is to use functional MRI (fMRI) as an objective evaluation tool to describe the brain functional changes of sensory projections after immediate or secondary breast reconstruction.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Functional Cerebral MRI Evaluation of Integration of Breast Reconstruction into the Body Schema.
Régis C, Le Deley MC, Bogart E, Leguillette C, et al · · 2022 · PMID 34839425 · DOI 10.1245/s10434-021-11048-0
Verify or expand the search:
- PubMed search for NCT02553967
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Functional MRI
Trials testing the same drug.
- NCT06797661 — Insights Into the Pathophysiology of Neurovascular Uncoupling in Patients with Brain Lesions. · NA · recruiting
- NCT06506019 — Neurobiological Effects of Psilocybin in Treatment Resistant Bipolar Depression · Phase 1 · recruiting
- NCT06471179 — Functional Magnetic Resonance Imaging Study in Schizophrenia Patients and Correlation With Cognitive Impairments · not yet recruiting
- NCT06355284 — Overcontrol and Suicide in PTSD · active not recruiting
- NCT05498532 — Functional MRI Evaluation in Pyeloureteral Junction Syndrome in Children · unknown
Other recruiting trials for Breast Cancer
Currently open trials in the same condition.
- NCT06148038 — CBD for Breast Cancer Primary Tumors · Phase 1 · recruiting
- NCT07405801 — A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus R · Phase 2 · recruiting
- NCT07285993 — Detection and Outcomes in Metastatic Invasive Lobular Breast Cancer Through Novel F-18 FAP PET · Phase 2 · recruiting
- NCT07510698 — Same-Day Awake Mastectomy With Immediate Breast Reconstruction for Patients With Breast Cancer · NA · recruiting
- NCT06768931 — Biolosion Combined Standard Neoadjuvant Therapy to Treat Triple-negative Breast Cancer · Phase 2 · recruiting
Other Centre Oscar Lambret trials
Trials by the same sponsor.
- NCT07507773 — Assessment of the Long-term Efficacy of Moderately Hypofractionated Neoadjuvant Radiotherapy Soft Tissue Sarcoma in the · Phase 2 · not yet recruiting
- NCT06807164 — Serratus Plane Block (SPB) Versus Capsaïcine Versus Botox-A for Chronic Neuropathic Pain in Post-mastectomy Syndrome · Phase 2 · recruiting
- NCT06969833 — Prospective Clinico-biological Database of Patients With Ovarian and/or Peritoneal and/or Fallopian Tube Carcinoma · NA · recruiting
- NCT06181201 — Association Between the Composition of the Intestinal Microbiota and Tumor Response in Locally Advanced Rectal Cancer · terminated
- NCT05286684 — Feasibility of Exosome Analysis in Cerebrospinal Fluid During the Diagnostic Workup of Metastatic Meningitis · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02553967 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Centre Oscar Lambret
- Last refreshed: 17 March 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02553967.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing